HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options. [electronic resource]
Producer: 20120416Description: 40-5 p. digitalISSN:- 1473-7760
- Adenocarcinoma -- chemistry
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Biomarkers, Tumor -- analysis
- Clinical Trials, Phase III as Topic
- Drug Therapy, Combination
- Esophageal Neoplasms -- chemistry
- Humans
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- analysis
- Stomach Neoplasms -- chemistry
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.